Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81600741)
  • National Natural Science Foundation of China (81670866)
  • Sun Yat-sen University (19ykpy152)
  • Natural Science Foundation of Guangdong Province (2020A1515011099)
  • Fundamental Research Funds for the Central Universities

This publication has 39 references indexed in Scilit: